期刊文献+

HPLC法测定注射用多西他赛纳米粒中溶血磷脂酰胆碱含量 被引量:1

Determination of lysophosphatidylcholine in nanoparticles of docetaxel for injection by HPLC
原文传递
导出
摘要 目的:建立高效液相色谱法测定注射用多西他赛纳米粒中溶血磷脂酰胆碱含量。方法:采用Xtimate C18(4.6 mm×250mm,5μm)色谱柱,以0.08 mol·L-1磷酸二氢钾水溶液(A)-乙腈(B)为流动相进行梯度洗脱(0~20 min,50%B;20~22min,50%B→70%B;22~32 min,70%B;32~34 min,70%B→50%B;34~50 min,50%B),流速1.2 mL·min-1,柱温35℃,紫外检测波长210 nm。结果:在选定条件下,溶血磷脂酰胆碱与样品其他组分分离良好,溶血磷脂酰胆碱峰面积与浓度在0.03~0.25 mg·L-1范围内具有良好线性关系,r=0.9997;检测限0.2μg,定量限0.4μg;平均回收率在99%~105%,RSD〈6%。结论:经方法学验证表明,该方法可用于注射用多西他赛纳米粒中溶血磷脂酰胆碱含量测定。 Objective: To establish an HPLC method for determining lysophosphatidylcholine in nanoparticles of docetaxel for injection. Methods: The separation was performed on the Xtimate C18column( 4. 6 mm × 250 mm,5 μm), the mobile phase consisted of 0. 08 mol·L-1potassium dihydrogen phosphate( A) and acetonitrile( B) with a gradient elution( 0-20 min,50% B; 20-22 min,50% B→70% B; 22-32 min,70% B; 32-34 min,70% B→50% B; 34-50 min,50% B) at a flow rate of 1. 2 mL·min-1. The column temperature was 35 ℃,and the detection wavelength was at 210 nm. Results: Under the described condition,lysophosphatidylcholine was completely separated from other components in nanoparticles of docetaxel for injection. Good linear relationship was observed between the peak area of lysophosphatidylcholinethe and concentration in the range of 0. 03-0. 25 mg·L-1,r =0. 9997. The limit of detection was 0. 2 μg,and the limit of quantitation was 0. 4 μg. The average recovery of lysophosphatidylcholine ranged from 99% to 105%. The relative standard deviations were less than 6%. Conclusion: It is confirmed by the methodology validation that the quantification method is applicable to the quality control of lysophosphatidylcholine in nanoparticles of docetaxel for injection.
出处 《药物分析杂志》 CAS CSCD 北大核心 2014年第5期874-878,共5页 Chinese Journal of Pharmaceutical Analysis
基金 国家重大新药创制项目之化学新药质量标准研究与评价技术平台(2011ZX09303-001)
关键词 紫杉烷类抗肿瘤药物 多西他赛 纳米粒制剂 溶血磷脂酰胆碱检测 高效液相色谱法 antineoplastic taxane drugs docetaxel nanoparticle preparations lysophosphatidylcholine assay HPLC
  • 相关文献

参考文献15

二级参考文献46

共引文献73

同被引文献12

引证文献1

二级引证文献1

  • 1国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院,中国医疗保健国际交流促进会临床药学分会,中国抗癌协会肿瘤临床药学分会,肺癌治疗相关中成药药学服务专家共识制定组,戚姝娅,李国辉,戴媛媛,张玉君,张铭予.肺癌治疗相关中成药药学服务专家共识(2024)[J].中国医院用药评价与分析,2024,24(10):1153-1166. 被引量:2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部